The investment seeks to provide long-term capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MidCapValue
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBP | 91.63 | 1.62 | +1.80% |
| Virtus LifeSci Biotech Products ETF | |||
| OPTZ | 49.36 | 0.62 | +1.26% |
| Optimize Strategy Index ETF | |||
| EUFN | 39.10 | 0.37 | +0.96% |
| iShares MSCI Europe Financials ETF | |||
| ABLD | 30.24 | -0.02 | -0.05% |
| Abacus FCF Real Assets Leaders ETF | |||
| FGDL | 55.84 | -0.30 | -0.53% |
| Franklin Responsibly Sourced Gold ETF | |||
A.I.dvisor indicates that over the last year, RVACX has been closely correlated with VEVYX. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if RVACX jumps, then VEVYX could also see price increases.
| Ticker / NAME | Correlation To RVACX | 1D Price Change % | ||
|---|---|---|---|---|
| RVACX | 100% | N/A | ||
| VEVYX - RVACX | 93% Closely correlated | N/A | ||
| JVMRX - RVACX | 88% Closely correlated | N/A | ||
| MVCAX - RVACX | 80% Closely correlated | N/A | ||
| VMVIX - RVACX | 73% Closely correlated | N/A | ||
| VMVAX - RVACX | 73% Closely correlated | N/A | ||
More | ||||